Accurna
Pioneering drug delivery systems for nucleic acid therapeutics
Tokyo, Japan · Founded 2015
- Headquarters
- Tokyo
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Website
- accurna.com
- Last Round
- SeedDec 2015
- Rounds
- 1
About
AccuRna is a Japanese biotech startup founded in 2015 and headquartered in Tokyo, Japan, dedicated to the development of nucleic acid therapeutics with a focus on innovative drug delivery systems (DDS). The company pioneers unique DDS platforms capable of delivering both short-chain nucleic acids (ASO, siRNA, miRNA) and long-chain mRNA as therapeutic drugs. AccuRna's goal is to promote therapeutic innovation and provide effective treatments for refractory diseases with high unmet medical needs, leveraging nano micelle and other advanced delivery technologies to achieve safe and efficient nucleic acid medicine delivery.
Summary
Accurna is a Biotech company based in Tokyo, Japan, founded in 2015. Its most recent funding was a Seed round in Dec 2015. Investors include Fast Track Initiative, and UTokyo Innovation Platform.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2015
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/accurna"><img src="https://indexed.vc/api/badge/company/accurna" alt="Accurna on Indexed.vc" width="260" height="76" /></a>